Latest News and Press Releases
Want to stay updated on the latest news?
-
BVI Medical, announced that it has received 510(k) clearance from the U.S. FDA for its innovative glaucoma surgical system, Leos™
-
COLUMBIA, Md., April 17, 2025 (GLOBE NEWSWIRE) -- CSSi LifeSciences, a global regulatory consulting firm specializing in guiding drug and medical device companies through FDA approvals, is excited...
-
Ramat Gan, Israel, April 17, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs...
-
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
-
Salt Lake City, UT, April 11, 2025 (GLOBE NEWSWIRE) -- Leading kratom brand MIT45 is taking a definitive stand against the unsafe, unethical, and illegal practice of synthesizing...
-
Advanced BVA System Designed for Faster, Simpler Bedside Testing Oak Ridge, TN, April 10, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), a leader in blood volume measurement technology,...
-
TORONTO and HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to provide a business update and...
-
Parasol group recommended reduction in proteinuria over 24 months as a surrogate endpoint for full approval of FSGS drugs.
-
L’approbation de la FDA permet une distribution sans restriction d’EGRIFTA SVMD, levant ainsi l'incertitude concernant tous les lots fabriqués L’approbation du PAS fait suite à l’approbation...
-
FDA action allows for unrestricted distribution of EGRIFTA SV®, removing uncertainty with respect to all manufactured batches PAS approval follows recent FDA approval of new formulation, EGRIFTA...